ClinicalTrials.Veeva

Menu

Liverpool Care Pathway for the Dying at Residential Care Homes

U

Umeå University

Status

Completed

Conditions

End-of-life Care

Treatments

Other: Liverpool care pathway

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.

Full description

All residential care homes in Skellefteå municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.

Enrollment

260 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • nursing homes in Skellefteå municipality, Sweden

Exclusion criteria

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

260 participants in 2 patient groups

Liverpool care pathway
Other group
Description:
Liverpool care pathway for dying at nursing homes
Treatment:
Other: Liverpool care pathway
control
No Intervention group
Description:
Usual care is performed for the control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems